MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
about
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) origin and animal reservoirMiddle East respiratory syndrome: obstacles and prospects for vaccine developmentMiddle East respiratory syndrome coronavirus (MERS-CoV): animal to human interactionAnimal models of Middle East respiratory syndrome coronavirus infectionDromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV).Risk factors for MERS coronavirus infection in dromedary camels in Burkina Faso, Ethiopia, and Morocco, 2015A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.Bat origin of human coronaviruses.Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus.Absence of MERS-CoV antibodies in feral camels in Australia: Implications for the pathogen's origin and spreadDromedary camels in northern Mali have high seropositivity to MERS-CoVMiddle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseMiddle East respiratory syndrome coronavirus: epidemiology and disease control measuresMERS coronavirus: diagnostics, epidemiology and transmission.Acute middle East respiratory syndrome coronavirus infection in livestock Dromedaries, Dubai, 2014.Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, KenyaReplication and shedding of MERS-CoV in Jamaican fruit bats (Artibeus jamaicensis)Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission.Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in AlpacasMERS-CoV Antibodies in Humans, Africa, 2013-2014.Hepatitis E Virus Infection in Dromedaries, North and East Africa, United Arab Emirates, and Pakistan, 1983-2015.Middle East respiratory syndrome vaccines.MERS-CoV recombination: implications about the reservoir and potential for adaptation.Link of a ubiquitous human coronavirus to dromedary camels.Time Course of MERS-CoV Infection and Immunity in Dromedary Camels.Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt.Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012-2015MERS and the dromedary camel trade between Africa and the Middle East.An update on Middle East respiratory syndrome: 2 years later.Host Factors in Coronavirus Replication.No Serologic Evidence of Middle East Respiratory Syndrome Coronavirus Infection Among Camel Farmers Exposed to Highly Seropositive Camel Herds: A Household Linked Study, Kenya, 2013.A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.Evidence for an Ancestral Association of Human Coronavirus 229E with Bats.Vaccines against Middle East respiratory syndrome coronavirus for humans and camels.Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapyMERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation.MERS-coronavirus: From discovery to intervention.Risk of global spread of Middle East respiratory syndrome coronavirus (MERS-CoV) via the air transport network.
P2860
Q26743813-DB7F0B82-9DDF-4D7B-BBAB-8AC34A1B7663Q27013314-F14A38A3-2582-4D4F-94CB-EB613DB0FBDFQ28073640-1BC79643-2A04-42B9-A845-70D804201663Q28086778-7E019BB3-D5AC-4939-949A-18590BD81802Q30252107-A8E62D72-5BB9-49C7-AAAB-19CF41EDDD47Q30377495-8618BAE2-2B4F-4ACB-880C-9214AD3397A5Q30378994-0D0450B5-F519-4EFC-BA4F-2337B3D6F95BQ30382750-E2AA742A-CD86-4636-A1BE-C694F3F44908Q30400728-E7C7AB3A-3613-4F91-ABAA-92C49C739B52Q33718283-DD5A3732-6743-4204-877E-C4C8BDEFA5B9Q33753550-8730A141-21E9-4081-B242-5661B26F78F9Q34468689-1C271A05-0B50-4745-B97A-DD72EBAACEE1Q34482795-227FC263-524A-43D1-BE94-B63E686FA891Q34506268-0D6FCB0A-CD9A-4F63-9466-8F8D1579A2F6Q35673405-34B1C24C-378C-4A94-A858-D76C48344E8AQ35810274-B476B8C0-C282-4AD8-B6B9-C870318EBF51Q36602236-33FAFB5C-90F6-47C3-855A-F2F7691605FDQ36865015-B1DBFBD8-6E8D-44C8-9FDB-A274B48CBE1CQ36935230-FAB09468-74FB-4E56-9293-174ABC8C51F5Q36935271-0EB8499A-209E-44E9-8382-E6E13E676440Q37031450-7F651656-1029-45EB-A6AF-816054A1FDC7Q37143501-2C0F6B64-8A25-4409-9B63-A6978809E6A2Q37186725-1EB90EDA-0208-46D5-B7DE-5EAE25C267EDQ37258495-6BF406E2-A43C-45D7-9477-93811C62DD63Q37535800-7D373302-2C03-4209-A725-85B261E99B8DQ37617630-C7AC8357-C3FF-4BA5-A4E0-7B99C4A72AA4Q37708530-B325439B-5E64-4225-93C6-28E0C9847254Q37717377-BE3F0093-DAD2-45F8-8BAC-5FB8D56622C3Q37739645-4B942DB7-0DED-4B06-8CFB-F8405D85E536Q38379691-234C7C2F-772B-4828-B46D-772A0328D754Q38384184-2C8CFFEA-31E7-4982-8CB3-30614701D81DQ38667715-9D5D2D3E-825B-4562-8950-1B9E56605C44Q38673951-79E19466-205D-4C14-8348-6913A5B4B71BQ38730484-A5184386-4549-42B5-BDC2-EDD733028018Q38953340-5DF9988D-00DB-47D8-85C8-41425B2B2835Q38992327-E9CD8576-67F5-49F3-A4E8-00105533CC7FQ38993000-E0289BD0-F17D-421F-8BF0-3981511CA2E5Q39269092-0A253B01-03DD-4964-B960-FCD861F97322Q39374922-9BF3B187-89D3-4911-B557-3DD98996DDA3Q39416141-51E26070-F0D3-4AB7-8CB1-01D8ACE7CBE8
P2860
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@ast
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@en
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@nl
type
label
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@ast
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@en
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@nl
prefLabel
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@ast
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@en
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@nl
P2093
P2860
P50
P356
P1476
MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
@en
P2093
Anne Liljander
Bakri E Musa
Benjamin Meyer
Berend-Jan Bosch
Mario Younan
Mosaad Hilali
Set Bornstein
P2860
P304
P356
10.3201/EID2012.141026
P577
2014-12-01T00:00:00Z